HRT Financial’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Sell |
106,280
-37,563
| -26% | -$46.3K | ﹤0.01% | 1855 |
|
|
2025
Q1 | $169K | Buy |
+143,843
| New | +$169K | ﹤0.01% | 1831 |
|
|
2023
Q4 | – | Sell |
-134,188
| Closed | -$1.12M | – | 2654 |
|
|
2023
Q3 | $1.12M | Buy |
134,188
+109,475
| +443% | +$914K | 0.01% | 822 |
|
|
2023
Q2 | $328K | Buy |
+24,713
| New | +$328K | ﹤0.01% | 1431 |
|
|
2022
Q4 | – | Sell |
-151,070
| Closed | -$876K | – | 2752 |
|
|
2022
Q3 | $876K | Buy |
+151,070
| New | +$876K | 0.01% | 972 |
|
|
2022
Q2 | – | Sell |
-129,950
| Closed | -$1.18M | – | 3340 |
|
|
2022
Q1 | $1.18M | Buy |
+129,950
| New | +$1.18M | 0.01% | 824 |
|
|
2021
Q4 | – | Sell |
-41,001
| Closed | -$1.05M | – | 3524 |
|
|
2021
Q3 | $1.05M | Buy |
+41,001
| New | +$1.05M | 0.01% | 1096 |
|
|
2020
Q4 | – | Sell |
-240,493
| Closed | -$2.37M | – | 2214 |
|
|
2020
Q3 | $2.37M | Buy |
+240,493
| New | +$2.37M | 0.07% | 175 |
|
|
2019
Q2 | – | Sell |
-24,477
| Closed | -$176K | – | 844 |
|
|
2019
Q1 | $176K | Buy |
+24,477
| New | +$176K | 0.03% | 379 |
|